SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-015001
Filing Date
2019-03-15
Accepted
2019-03-15 07:07:37
Documents
2
Effectiveness Date
2019-03-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-2707_3defa14a.htm DEFA14A 28630
2 GRAPHIC g27073bgi001.gif GRAPHIC 151317
  Complete submission text file 0001104659-19-015001.txt   238144
Mailing Address 240 LEIGH FARM ROAD DURHAM NC 27707
Business Address 240 LEIGH FARM ROAD DURHAM NC 27707 919-806-4487
Dova Pharmaceuticals Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38135 | Film No.: 19682897
SIC: 2834 Pharmaceutical Preparations